Add to ORKGPCT Int. Appl. (2000), 41 pp. CODEN: PIXXD2 WO 0035904 A1 20000622 CAN 133:53675 AN 2000:42112
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
In response to the widespread use of beta-lactam antibiotics bacteria have evolved drug resistance m...
PCT Int. Appl. (2000), 41 pp. CODEN: PIXXD2 WO 0035904 A1 20000622 CAN 133:53675 AN 2000:421...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real ...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
beta-Lactamases are bacterial enzymes conferring resistance to beta-lactam antibiotics in clinicall...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
Embodiments of the present disclosure, in one aspect, relate to a beta-lactamase inhibitor, pharmace...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
In response to the widespread use of beta-lactam antibiotics bacteria have evolved drug resistance m...
PCT Int. Appl. (2000), 41 pp. CODEN: PIXXD2 WO 0035904 A1 20000622 CAN 133:53675 AN 2000:421...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
The invention provides novel non-/9-lactam inhibitors of ^-lactamases. In particular, the invention ...
Worldwide dissemination of pathogens resistant to almost all available antibiotics represent a real ...
Non-β-lactam inhibitors of β-lactamases are provided. In particular, the invention provides such in...
he invention relates to novel boronic acid compounds, a method for the preparation of such compounds...
beta-Lactamases are bacterial enzymes conferring resistance to beta-lactam antibiotics in clinicall...
The widespread use of beta-lactam antibiotics has lead to the worldwide appearance of drug-resistant...
Provided herein are heterocyclic compounds and pharmaceutical formulations that can be used to treat...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
Embodiments of the present disclosure, in one aspect, relate to a beta-lactamase inhibitor, pharmace...
With the aim of improving the ability of non-p-lactam inhibitors to inhibit AmpC-beta-tactamase, a s...
The invention provides novel non-$g(b)-lactam inhibitors of $g(b)-lactamases. In particular, the inv...
A small set of boronic acids acting as low nanomolar inhibitors of AmpC beta-lactamase were designed...
In response to the widespread use of beta-lactam antibiotics bacteria have evolved drug resistance m...